stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / TDOC

Teladoc Health, Inc. (TDOC)

Healthcare · Health Information Services · NYSE

Teladoc Health, Inc. (TDOC) posted $2.53B in revenue for fiscal 2025 (down 1.5% year over year), with a net loss of $200.32M, and has compounded revenue about 18.3%/yr over five years, per its SEC filings.

Data last refreshed June 15, 2026 from SEC filings · how we compute this

Price
$7.05
Market Cap
$1.27B
P/E Ratio
0.00
EPS
$-0.97
Sector
Healthcare
52-Week High
$9.77
52-Week Low
$4.40
Dividend Yield

Teladoc Health, Inc. revenue & earnings — last 10 fiscal years

Metric2016201720182019202020212022202320242025
Revenue$123.16M$233.28M$417.91M$553.31M$1.09B$2.03B$2.41B$2.60B$2.57B$2.53B
Gross profit$91.19M$171.66M$289.17M$368.84M$703.13M$1.38B$1.66B$1.84B$1.82B$1.76B
Net income$-74.22M$-106.78M$-97.08M$-98.86M$-485.14M$-428.79M$-13.66B$-220.37M$-1.00B$-200.32M
Net margin-60.3%-45.8%-23.2%-17.9%-44.3%-21.1%-567.5%-8.5%-39.0%-7.9%

Source: Teladoc Health, Inc. SEC filings (10-K). 13 years of history available in the interactive view.

What growth is priced into TDOC stock?

At today's market cap of $1.27B, Teladoc Health, Inc. is priced for free-cash-flow growth of about -2.9% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $137.33M from the FY ending 2025-12-31). For comparison, revenue 18.3%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →

Explore 13 years of Teladoc Health, Inc. financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track TDOC in your portfolio →

Teladoc Health, Inc. financial history by metric

About Teladoc Health, Inc.

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Teladoc Health, Inc. — frequently asked questions

What is Teladoc Health, Inc.'s revenue?

Teladoc Health, Inc. (TDOC) reported revenue of $2.53B for fiscal year 2025, down 1.5% from the prior year, according to its SEC filings.

Is Teladoc Health, Inc. profitable?

No — TDOC reported a net loss of $-200.32M in fiscal 2025.

What is TDOC's P/E ratio?

Teladoc Health, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.

How fast is Teladoc Health, Inc. growing?

TDOC's revenue grew at roughly 18.3% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

How much debt does Teladoc Health, Inc. have?

As of fiscal year 2025, TDOC carried roughly $994.92M in total debt (short- plus long-term borrowings), per its filed balance sheet.

What is Teladoc Health, Inc.'s gross margin?

TDOC's gross margin was 69.5% in fiscal 2025 — gross profit of $1.76B on revenue of $2.53B.

What is Teladoc Health, Inc.'s market cap?

Teladoc Health, Inc. (TDOC) has a market capitalization of about $1.27B, based on the latest data in our nightly-refreshed cache.

When does Teladoc Health, Inc.'s fiscal year end?

TDOC's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.

What growth is priced into TDOC stock?

At today's market cap of $1.27B, Teladoc Health, Inc. is priced for free-cash-flow growth of about -2.9% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $137.33M from the FY ending 2025-12-31). For comparison, revenue 18.3%/yr, computed from its SEC filings.

Where does this data come from?

All figures are computed from Teladoc Health, Inc.'s official SEC filings (10-K and 10-Q), covering 13 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 1,500+ companies → · Screen them by fundamentals →